-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 4, the Food and Drug Administration issued a notice on matters related to the implementation of the "Implementation Measures for the Early Resolution Mechanism for Drug Patent Disputes (Trial)"
The notice requires that from now on, the registration platform for patent information on listed drugs in China will be officially launched
From now on, when an applicant submits an application for listing registration of chemical generic drugs, Chinese medicines with the same name and same prescription, and biosimilar drugs, they shall submit patent declarations in accordance with the requirements of the Measures in accordance with the relevant drug patent information that has been disclosed on the Chinese drug patent information registration platform.